Innoviva (NASDAQ: INVA) reported Q3 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $33.3 million versus the consensus estimate of $37.74 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.